Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update.

IF 3.2 2区 医学 Q2 CLINICAL NEUROLOGY Journal of Neuro-Oncology Pub Date : 2025-03-01 Epub Date: 2025-01-13 DOI:10.1007/s11060-024-04871-4
Navid Redjal, Mateo Ziu, Serah Choi, Patrick R Ng, Brain V Nahed, Jeffrey J Olson
{"title":"Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update.","authors":"Navid Redjal, Mateo Ziu, Serah Choi, Patrick R Ng, Brain V Nahed, Jeffrey J Olson","doi":"10.1007/s11060-024-04871-4","DOIUrl":null,"url":null,"abstract":"<p><p>Target populationAdults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas)QuestionIn adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), does surgical resection improve overall survival compared to observation or biopsy?Updated Recommendation from the Prior Version of These Guidelines:Level III: In adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), surgical resection is suggested over observation or biopsy to improve overall survival.Question Q2In adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), does maximal surgical resection improve progression free survival (PFS) and overall survival (OS) compared to subtotal resection/biopsy?Unchanged Recommendations from the Prior Version of These GuidelinesLevel II It is recommended that GTR or STR be accomplished instead of biopsy alone when safe and feasible so as to decrease the frequency of tumor progression recognizing that the rate of progression after GTR is fairly high.Level III Greater extent of resection can improve OS in WHO grade II diffuse gliomas patients. New RecommendationsLevel III: It is suggested that extent of resection be maximized as is safely possible for IDH mutant and IDHwt WHO grade II diffuse gliomas. to improve PFS and OS. Level III: There is insufficient evidence that greater extent of resection of 1p19q codeleted oligodendrogliomas (WHO grade II diffuse gliomas) improves OS Question Q3In adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), does the addition of intraoperative MRI and/or intraoperative ultrasound during surgery improve extent of resection?Unchanged Recommendation from the Prior Version of These GuidelinesLevel III: The use of intraoperative MRI is suggested to increase the extent of resection for adults with WHO grade II diffuse glioma.New RecommendationLevel III: The use of intraoperative ultrasound is suggested to increase the extent of resection compared to conventional surgery for adults with WHO grade II diffuse glioma.Question 4In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas) with seizures, does maximal surgical resection improve seizure control compared to observation or subtotal resection/biopsy?Updated Recommendation from the Prior Version of These GuidelinesLevel III: In adults with imaging consistent with a WHO Grade II diffuse glioma who present with seizure activity, surgical resection of greater than 90% of the lesion, when it can be accomplished safely, is suggested over observation or lesser extent of resection/biopsy to improve seizure control.New Questions and RecommendationsQuestion 5In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas), does use of intraoperative fluorescent guided surgery improve extent of resection?RecommendationLevel III: Intraoperative fluorescent guided surgery with 5-ALA is not suggested to improve the extent of resection for WHO grade II gliomas.Question 6In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas) in eloquent brain cortex, does awake craniotomy or other methods of intraoperative mapping increase extent of resection compared to conventional surgery without these techniques?RecommendationLevel III: It is suggested that awake craniotomy and other methods of intraoperative mapping can be used to increase the extent of resection for adults with WHO grade II diffuse glioma.Question 7In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas) in eloquent brain cortex, does use of advanced preoperative imaging modalities in the form of fMRI and/or DTI decrease surgical morbidity?RecommendationLevel III: The use of functional MRI and DTI related modalities are suggested to decrease surgical morbidity in adults with WHO grade II diffuse glioma.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":" ","pages":"99-152"},"PeriodicalIF":3.2000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-024-04871-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Target populationAdults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas)QuestionIn adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), does surgical resection improve overall survival compared to observation or biopsy?Updated Recommendation from the Prior Version of These Guidelines:Level III: In adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), surgical resection is suggested over observation or biopsy to improve overall survival.Question Q2In adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), does maximal surgical resection improve progression free survival (PFS) and overall survival (OS) compared to subtotal resection/biopsy?Unchanged Recommendations from the Prior Version of These GuidelinesLevel II It is recommended that GTR or STR be accomplished instead of biopsy alone when safe and feasible so as to decrease the frequency of tumor progression recognizing that the rate of progression after GTR is fairly high.Level III Greater extent of resection can improve OS in WHO grade II diffuse gliomas patients. New RecommendationsLevel III: It is suggested that extent of resection be maximized as is safely possible for IDH mutant and IDHwt WHO grade II diffuse gliomas. to improve PFS and OS. Level III: There is insufficient evidence that greater extent of resection of 1p19q codeleted oligodendrogliomas (WHO grade II diffuse gliomas) improves OS Question Q3In adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas), does the addition of intraoperative MRI and/or intraoperative ultrasound during surgery improve extent of resection?Unchanged Recommendation from the Prior Version of These GuidelinesLevel III: The use of intraoperative MRI is suggested to increase the extent of resection for adults with WHO grade II diffuse glioma.New RecommendationLevel III: The use of intraoperative ultrasound is suggested to increase the extent of resection compared to conventional surgery for adults with WHO grade II diffuse glioma.Question 4In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas) with seizures, does maximal surgical resection improve seizure control compared to observation or subtotal resection/biopsy?Updated Recommendation from the Prior Version of These GuidelinesLevel III: In adults with imaging consistent with a WHO Grade II diffuse glioma who present with seizure activity, surgical resection of greater than 90% of the lesion, when it can be accomplished safely, is suggested over observation or lesser extent of resection/biopsy to improve seizure control.New Questions and RecommendationsQuestion 5In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas), does use of intraoperative fluorescent guided surgery improve extent of resection?RecommendationLevel III: Intraoperative fluorescent guided surgery with 5-ALA is not suggested to improve the extent of resection for WHO grade II gliomas.Question 6In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas) in eloquent brain cortex, does awake craniotomy or other methods of intraoperative mapping increase extent of resection compared to conventional surgery without these techniques?RecommendationLevel III: It is suggested that awake craniotomy and other methods of intraoperative mapping can be used to increase the extent of resection for adults with WHO grade II diffuse glioma.Question 7In adults with imaging suggestive of a WHO grade II diffuse glioma (oligodendrogliomas or astrocytomas) in eloquent brain cortex, does use of advanced preoperative imaging modalities in the form of fMRI and/or DTI decrease surgical morbidity?RecommendationLevel III: The use of functional MRI and DTI related modalities are suggested to decrease surgical morbidity in adults with WHO grade II diffuse glioma.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
神经外科医师大会对弥漫性低级别胶质瘤患者手术治疗的系统评价和循证指南:更新。
成人影像学提示WHO II级弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)问题:对于影像学提示WHO II级弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)的成人,与观察或活检相比,手术切除是否能提高总生存率?这些指南先前版本的更新建议:III级:对于成像提示WHO II级弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)的成人,建议手术切除而不是观察或活检以提高总生存率。q2影像学提示WHO II级弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)的成人,与次全切除/活检相比,最大手术切除是否能改善无进展生存期(PFS)和总生存期(OS) ?在安全可行的情况下,建议行GTR或STR而不是单独活检,以减少肿瘤进展的频率,因为GTR后的进展率相当高。III级:WHOⅱ级弥漫性胶质瘤患者,更大程度的切除可改善OS。新的建议III级:建议对于IDH突变型和IDHwt WHO II级弥漫性胶质瘤,最大限度的切除是安全的。改进PFS和OS。III级:没有足够的证据表明更大程度的切除1p19q编码的少突胶质细胞瘤(WHO II级弥漫性胶质瘤)可以改善OS问题q3对于影像学提示为WHO II级弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)的成人,术中增加MRI和/或术中超声是否可以改善切除程度?III级:对于WHOⅱ级弥漫性胶质瘤的成人患者,建议术中使用MRI增加切除范围。新推荐III级:与常规手术相比,对于WHO II级弥漫性胶质瘤,建议术中使用超声来增加切除范围。在影像学提示患有WHO II级弥漫性胶质瘤(少突胶质瘤或星形细胞瘤)并癫痫发作的成人中,与观察或次全切除/活检相比,最大手术切除是否能改善癫痫控制?III级:对于成像符合WHO II级弥漫性胶质瘤且有癫痫发作活动的成人,在可以安全完成的情况下,建议对大于90%的病变进行手术切除,以观察或较小程度的切除/活检来改善癫痫发作控制。新问题和建议在影像学提示WHO II级弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)的成人中,术中荧光引导手术是否能改善切除程度?III级推荐:术中荧光引导5-ALA手术不建议改善WHO II级胶质瘤的切除范围。问题6:对于有WHO II级脑皮层弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)影像学提示的成人,与没有这些技术的常规手术相比,清醒开颅术或其他术中定位方法是否增加了切除范围?建议III级:对于WHO II级弥漫性胶质瘤的成人患者,建议采用清醒开颅和其他术中定位方法来增加切除范围。问题7:在有世卫组织II级脑皮层弥漫性胶质瘤(少突胶质细胞瘤或星形细胞瘤)影像学提示的成年人中,使用功能磁共振成像和/或DTI形式的先进术前成像方式是否能降低手术发病率?建议III级:建议使用功能性MRI和DTI相关的方式来降低WHO II级弥漫性胶质瘤的成人手术发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Neuro-Oncology
Journal of Neuro-Oncology 医学-临床神经学
CiteScore
6.60
自引率
7.70%
发文量
277
审稿时长
3.3 months
期刊介绍: The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
期刊最新文献
Correction to: Single-cell RNA-seq reveals diverse molecular signatures associated with Methotrexate resistance in primary central nervous system lymphoma cells. The LITT Fit in neuro-oncology: indications, imaging, and adjunctive therapies. A systematic review of stereotactic radiosurgery for metastatic spinal sarcomas. Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutant. Single-cell RNA-seq reveals diverse molecular signatures associated with Methotrexate resistance in primary central nervous system lymphoma cells.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1